Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPular ATLANTIS trial
2023-504637-42-01Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Dec 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial of aspirin, clopidogrel, apixaban, edoxaban, rivaroxaban and 4 more in aortic stenosis (AS) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Thromboembolic events and All bleeding. Planned start Dec 2023; status: authorised.
02
Drugs
aspirinclopidogrelapixabanedoxabanrivaroxaban
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2023-504637-42-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504637-42-01.